Do Vitamin E and Ferulic Acid Actually Stabilise Topical Vitamin C?

Bar chart: tetrahexyldecyl ascorbate alone is fully degraded at 6 minutes under singlet oxygen, and 25% degraded at 10 minutes when combined with a stabilising antioxidant. Source: Swindell et al., Int J Mol Sci 2021;22:8756.

Yes, in the specific systems where it has been measured — but oxidative stability is a property of the finished formulation, not of an ingredient. Adding ferulic acid to a solution of 15% L-ascorbic acid and 1% alpha-tocopherol improved the chemical stability of both vitamins and raised photoprotection of human skin from fourfold to approximately eightfold (Lin et al., 2005).

Published 15 September 2026 · Last reviewed 15 September 2026

The terms, defined

Oxidative stability is the extent to which a molecule retains its original chemical structure when exposed to oxygen, light, heat or reactive oxygen species. It is always measured on a particular preparation under stated conditions; a figure obtained in one system does not carry over to another.

A co-antioxidant is a second reducing agent included in a formulation so that it is oxidised preferentially, or so that it returns the primary active to its reduced state. Its function is not to contribute a separate effect but to keep the principal molecule intact.

Ferulic acid is a hydroxycinnamic acid present in plant cell walls, used in topical preparations for its antioxidant properties.

Tetrahexyldecyl ascorbate (THDC) is a lipid-soluble ester of ascorbic acid, adopted in topical preparations where a low-pH aqueous system is not practical. It requires conversion in tissue rather than acting as ascorbate itself.

What the three-component solution measured

The reference experiment is a 2005 study in the Journal of Investigative Dermatology. A topical solution of 15% L-ascorbic acid with 1% alpha-tocopherol was compared with the same solution containing ferulic acid, on skin exposed to solar-simulated irradiation. The authors report that the addition "improved chemical stability of the vitamins (C+E) and doubled photoprotection to solar-simulated irradiation of skin from 4-fold to approximately 8-fold as measured by both erythema and sunburn cell formation" (Lin et al., 2005, J Invest Dermatol 125:826–832).

Two further observations are reported in the same work: reduced induction of caspase-3 and caspase-7, and reduced thymine dimer formation. The authors conclude that the combination "should be useful for protection against photoaging and skin cancer". That is their statement about an experimental antioxidant solution, not a claim that can be made for a cosmetic product in either the European Union or the United States; disease prevention falls outside the cosmetic category in both frameworks.

Why ascorbate and tocopherol behave as a pair

The pairing is not arbitrary. Alpha-tocopherol intercepts radicals in lipid membranes and is itself oxidised in the process. Ascorbate acts, in the wording of a 2017 review in Nutrients, as "a regenerator of oxidised vitamin E, thereby effectively recycling this important lipid-soluble radical scavenger and limiting oxidative damage to cell membrane structures" (Pullar, Carr & Vissers, 2017, Nutrients 9:866).

The consequence for formulation is that the two molecules occupy different compartments — one lipid, one aqueous — and that the water-soluble partner is consumed in maintaining the lipid-soluble one. A system built on this chemistry therefore has a finite working life determined by how much reducing capacity it carries and how much oxygen it meets.

The same principle applied to the lipid-soluble ester

The ester route was adopted to escape the pH ceiling that governs L-ascorbic acid penetration. It does not escape oxidation. In a 2021 study in the International Journal of Molecular Sciences, THDC exposed to singlet oxygen "degraded completely by 6 min" in the absence of a stabilising antioxidant. With acetyl zingerone present, "there was only a 25% degradation of THDC after 10 min" (Swindell et al., 2021, Int J Mol Sci 22:8756).

The same work records two findings that complicate the simplified commercial account of this ingredient. THDC is described by its investigators as "a poor antioxidant". And as a standalone ingredient it "led to unexpected activation of type I interferon signaling" in reconstructed human epidermis, with up-regulation of genes including MX1, MX2 and STAT2 — an effect the authors report as blunted when the stabilising antioxidant was present.

Neither observation disqualifies the ester. Both describe a condition of use: the molecule performs as intended inside a system that protects it, and behaves differently outside one. The pH and delivery side of the same question is set out in our open-access technical report, Topical Vitamin C: the pH Constraint on L-Ascorbic Acid and the Oxidative Stability of Tetrahexyldecyl Ascorbate (DOI 10.5281/zenodo.22491021, CC BY 4.0), which records a measured antioxidant capacity for THDC of 1035 µM Trolox equivalents per gram.

What each study actually measured

System Model Reported outcome Source
15% L-ascorbic acid + 1% alpha-tocopherol Human skin, solar-simulated irradiation Fourfold photoprotection (erythema and sunburn cell formation) Lin et al., 2005
15% L-ascorbic acid + 1% alpha-tocopherol + ferulic acid Human skin, solar-simulated irradiation Approximately eightfold photoprotection; improved chemical stability of both vitamins; reduced thymine dimer formation Lin et al., 2005
Tetrahexyldecyl ascorbate, alone In vitro, singlet oxygen exposure Complete degradation by 6 minutes Swindell et al., 2021
Tetrahexyldecyl ascorbate + acetyl zingerone In vitro, singlet oxygen exposure 25% degradation at 10 minutes Swindell et al., 2021
Acetyl zingerone, alone UVA/UVB exposure, 4 hours More than 80% remaining Swindell et al., 2021

What these results do not establish

Three limits are worth stating plainly, because the published record supports them and the abbreviated version of the argument does not.

The figures are system-specific. An eightfold value was obtained for one solution, at one concentration pair, under one irradiation protocol. It is not a property of ferulic acid, and it does not transfer to a different vehicle, a different pH or a different concentration.

Degradation kinetics were measured in vitro. The six-minute and ten-minute figures describe behaviour under a defined singlet-oxygen challenge, not the shelf life of a packaged product or the residence time of the molecule on skin.

An ester is not ascorbate. A lipid-soluble derivative must be converted in tissue before it can act through ascorbate chemistry, and the efficiency of that conversion is a separate question from the stability figures above.

Taken together, the evidence supports a narrow and defensible statement: co-formulation with a second antioxidant measurably slows the loss of the primary ascorbate species in the systems tested. It does not support describing any ascorbate preparation as stable without naming the system, the conditions and the measurement.

References

  1. Lin, F.-H., Lin, J.-Y., Gupta, R. D., Tournas, J. A., Burch, J. A., Selim, M. A., Monteiro-Riviere, N. A., Grichnik, J. M., Zielinski, J. & Pinnell, S. R. (2005). Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. Journal of Investigative Dermatology, 125(4), 826–832. DOI 10.1111/j.0022-202X.2005.23768.x · PMID 16185284
  2. Swindell, W. R., Randhawa, M., Quijas, G., Bojanowski, K. & Chaudhuri, R. K. (2021). Tetrahexyldecyl ascorbate (THDC) degrades rapidly under oxidative stress but can be stabilized by acetyl zingerone to enhance collagen production and antioxidant effects. International Journal of Molecular Sciences, 22(16), 8756. DOI 10.3390/ijms22168756
  3. Pullar, J. M., Carr, A. C. & Vissers, M. C. M. (2017). The roles of vitamin C in skin health. Nutrients, 9(8), 866. DOI 10.3390/nu9080866
  4. TTS Clinical Scientific Team (2026). Topical Vitamin C: the pH Constraint on L-Ascorbic Acid and the Oxidative Stability of Tetrahexyldecyl Ascorbate, version 1.0. Zenodo. DOI 10.5281/zenodo.22491021 (CC BY 4.0)

Scope

This article describes findings reported in the published scientific literature and in an open-access technical report. It is not a claim of efficacy, performance or benefit for any cosmetic product, and it is not medical advice. Cosmetic products are not intended to diagnose, treat, cure or prevent any disease.